No Data
No Data
Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (JAZZ), Acadia Healthcare (ACHC) and Genmab (GMAB)
TD Cowen Maintains Genmab(GMAB.US) With Hold Rating
TD Cowen Reaffirms Their Hold Rating on Genmab (GMAB)
RBC Capital Keeps Their Buy Rating on Genmab A/S (0MGB)
Top Gap Ups and Downs on Thursday: CIEN, WBD, ADBE and More
Genmab to Hold 2024 R&D Update and ASH Data Review Meeting